PFLPhysiological Fitness Landscape

Biomarkers · Urine Biomarkers

Urine Specific Gravity

U-shaped: both low and high values carry risk. Not measured in our NHANES panel; the curve is synthesised from the published association.

Hazard ratio relative to the curve's reference value, as synthesised from the published association.

Published hazard ratio1.29top vs bottom quarter (95% CI 1.11–1.50) · NHANES III Prospective Mortality Linkage (1988-2011)

Where people sit

Population percentiles (ratio) by sex and age band. Cycle or source as recorded in the catalogue.

SexAge5th25thMedian75th95thnCycle / source
All20-391.011.011.021.021.032,5602017-2018
All40-591.011.011.021.021.032,5402017-2018
All60+1.001.011.021.021.032,6502017-2018
Allall1.011.011.021.021.037,7502017-2018
Menall1.011.011.021.021.033,7602017-2018
Womenall1.001.011.021.021.033,9902017-2018

What studies found when this marker was changed

Effects on the biomarker reported in the cited studies. They describe what happened in those populations, not a recommendation for anyone. See all catalogued interventions.

TypeInterventionReported effectEvidenceSource
clinicalEnd-stage renal medullary destruction / isosthenuriaFixed specific gravity at 1.010 unable to concentrate or diluteclinical guidelineRose BD, Post TW. Clinical physiology of acid-base and electrolyte disorders. 5t…
dietConsistent daily fluid hydration (2.5-3.5 L/day water intake)Maintains urine specific gravity in optimal euvolemic range (1.010-1.020)cohortNational Center for Health Statistics. National Health and Nutrition Examination…
environmentalSevere hypertonic dehydration and heat exhaustion+0.015 to +0.025 elevation (USG > 1.030)prospective cohortCasa DJ, et al. J Athl Train. 2000;35:212-224.
exerciseElectrolyte and fluid replacement during heavy endurance exercisePrevents hypersthenuric dehydration (USG > 1.030)rctSawka MN, et al. Med Sci Sports Exerc. 2007;39:377-390.
lifestyleStructured consistent hydration (2.5-3.5 L/day water intake)Maintains optimal euhydrated USG (1.012-1.018)rctArmstrong LE, et al. Int J Sport Nutr Exerc Metab. 2010;20:471-479.
pharmacologicDesmopressin (dDAVP) therapy in central diabetes insipidusIncreases hyposthenuric USG from <1.005 to >1.015clinical guidelineFenske W, et al. N Engl J Med. 2018;379:428-439.